The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cystadenomas and Cystadenocarcinomas of the Pancreas: A Multiinstitutional Retrospective Study of 398 Cases
Open accessAbstract
OBJECTIVE: To review the features of patients with benign and malignant cystadenomas of the pancreas, focusing on preoperative diagnostic accuracy and long-term outcome, especially for nonoperated serous cystadenomas and resected cystadenocarcinomas. SUMMARY BACKGROUND DATA: Serous cystadenomas (SCAs) are benign tumors. Mucinous cystic neoplasms should be resected because of the risk of malignant progression. A correct preoperative diagnosis of tumor type is based on morphologic criteria. Despite the high quality of recent imaging procedures, the diagnosis frequently remains uncertain. Invasive investigations such as endosonography and diagnostic aspiration of cystic fluid may be helpful, but their assessment is limited to small series. The management of typical SCA may require resection or observation. Survival after pancreatic resection seems better for cystadenocarcinomas (MCACs) than for ductal adenocarcinomas of the pancreas. METHODS: Three hundred ninety-eight cases of cystadenomas of the pancreas were collected between 1984 and 1996 in 73 institutions of the French Surgical Association. Clinical presentation, radiologic evaluation, and surgical procedures were analyzed for 144 operated SCAs, 150 mucinous cystadenomas (MCAs), and 78 MCACs. The outcome of 372 operated patients and 26 nonoperated patients with SCA was analyzed. RESULTS: Cystadenomas represented 76% of all primary pancreatic cystic tumors (398/522). An asymptomatic tumor was discovered in 32% of patients with SCA, 26% of those with MCA, and 13% of those with MCAC. The tumor was located in the head or uncinate process of the pancreas in 38% of those with SCA, 27% of those with MCA, and 49% of those with MCAC. A communication between the cyst and pancreatic duct was discovered in 0.6% of those with SCA, 6% of those with MCA, and 10% of those with MCAC. The main investigations were ultrasonography and computed tomography (94% for SCA, MCA, and MCAC), endosonography (34%, 28%, and 22% for SCA, MCA, and MCAC respectively), endoscopic retrograde cholangiopancreatography (16%, 14%, 22%), and cyst fluid analysis (22%, 31%, 35%). An accurate preoperative diagnosis of tumor type was proposed for 20% of those with SCA (144 cases), 30% of those with MCA, and 29% of those with MCAC. An atypical unilocular macrocyst was observed in 10% of SCA cases. The most common misdiagnosis for mucinous cystic tumors was pseudocyst (9% of MCAs, 15% of MCACs). Intraoperative frozen sections (126 cases) allowed a diagnosis according to definitive histologic examination in 50% of those with SCA and MCA and 62% of those with MCAC. For management, 93% of patients underwent surgery. Nonoperated patients (7%) had exclusively typical SCA. A complete cyst excision was performed in 94% of benign cystadenomas, with an operative mortality rate of 2% for SCA and 1.4% for MCA. Resection was possible in 74% of cases of MCAC. Mean follow-up of 26 patients with nonresected SCAs was 38 months, and no patients required surgery. For resected MCACs, the actuarial 5-year survival rate was 63%. CONCLUSIONS: Spiral computed tomography is the examination of choice for a correct prediction of tumor type. Endosonography may be useful to detect the morphologic criteria of small tumors. Diagnostic aspiration of the cyst allows differentiation of the macrocystic form of SCA (10% of cases) and the unilocular type of mucinous cystic neoplasm from a pseudocyst. Surgical resection should be performed for symptomatic SCAs, all mucinous cystic neoplasms, and cystic tumors that are not clearly defined. Conservative management is wholly justified for a well-documented SCA with no symptoms. An extensive resection is warranted for MCAC because the 5-year survival rate may exceed 60%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yeo, C. J., Cameron, J. L., Sohn, T. A., Lillemoe, K. D., Pitt, H. A., Talamini, M. A., Hruban, R. H., Ord, S. E., Sauter, P. K., Coleman, J., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199709000-00004 · Cited by 1,783
Compagno, J., & Oertel, J. E. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.6.573 · Cited by 696
WARSHAW, A. L., COMPTON, C. C., LEWANDROWSKI, K., CARDENOSA, G., & MUELLER, P. R. (1990) · Annals of Surgery · doi:10.1097/00000658-199010000-00006 · Cited by 639
Hammel, P., Levy, P., Voitot, H., Levy, M., Vilgrain, V., Zins, M., Flejou, J.-F., Molas, G., Ruszniewski, P., & Bernades, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90224-4 · Cited by 258
Castillo, C. F.-D., & Warshaw, A. L. (1995) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)46742-3 · Cited by 243
The Spectrum of Serous Cystadenoma of the Pancreas Clinical, Pathologic, and Surgical Aspects
Pyke, C., van Heerden, J. A., Colby, T. V., Sarr, M. G., & Weaver, A. L. (1992) · Annals of Surgery · doi:10.1097/00000658-199202000-00007 · Cited by 242
Cystic pancreatic tumors: CT and sonographic assessment
Johnson, C., Stephens, D., Charboneau, J., Carpenter, H., & Welch, T. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.151.6.1133 · Cited by 240
Serous Cystadenocarcinoma of the Pancreas: A New Entity?
George, D. H., Murphy, F., Michalski, R., & Ulmer, B. G. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198901000-00009 · Cited by 229
Cystadenomas of the Pancreas: Is Enucleation an Adequate Operation?
Talamini, M. A., Moesinger, R., Yeo, C. J., Poulose, B., Hruban, R. H., Cameron, J. L., & Pitt, H. A. (1998) · Annals of Surgery · doi:10.1097/00000658-199806000-00013 · Cited by 181
Lewandrowski, K. B., Warshaw, A. L., & Compton, C. C. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90397-l · Cited by 180
Cited by
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417
Balcom IV, J. H. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.4.391 · Cited by 769
Castillo, C. F.-D. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.4.427 · Cited by 618
Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis
van der Waaij, L. A., van Dullemen, H. M., & Porte, R. J. (2005) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(05)01581-6 · Cited by 612
Metadata
- Authors
- Le Borgne, J., de Calan, L., & Partensky, C.
- Venue
- Annals of Surgery
- Published
- 1999-08
- Volume
- 230
- Issue
- 2
- Pages
- 152
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2333027375
- Cited by
- 480
- References
- 20
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cystadenomas and Cystadenocarcinomas of the Pancreas: A Multiinstitutional Retrospective Study of 398 Cases. https://app.cochat.ai/papers/10.1097/00000658-199908000-00004
- The paper
- Le Borgne, J., de Calan, L., & Partensky, C. (1999). Cystadenomas and Cystadenocarcinomas of the Pancreas: A Multiinstitutional Retrospective Study of 398 Cases. Annals of Surgery. https://doi.org/10.1097/00000658-199908000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.